EPG Wealth Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
VCM
VPM
EPG Wealth Management's GILD Position: Q1 2026 in Review
EPG Wealth Management reduced its Gilead Sciences (GILD) stake by 3.8% in Q1 2026, selling an estimated $23.7K and leaving 4,282 shares worth $597K. The position accounts for 0.16% of the portfolio, ranked #137.
EPG Wealth Management first reported a position in GILD in Q4 2019 and has held it in 14 quarters since. The position peaked at $977K in Q1 2023. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- EPG Wealth Management held 4,282 shares of Gilead Sciences worth $597K as of Q1 2026.
- EPG Wealth Management sold 169 Gilead Sciences shares in Q1 2026, an estimated $23.7K.
- Gilead Sciences made up 0.16% of EPG Wealth Management's portfolio in Q1 2026, its #137 holding.
- EPG Wealth Management first reported a position in Gilead Sciences in Q4 2019 and has held it in 14 quarters since.
- EPG Wealth Management's Gilead Sciences position peaked at $977K in Q1 2023.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on EPG Wealth Management's 13F filing for Q1 2026, filed 7 May 2026.